Breast Cancer Is Predicted To Increase To 38 Percent By 2050

JAKARTA - Breast cancer in women is predicted to increase rapidly in 2050. In the research published in Forbes, it was stated that in that year, women in the world who had breast cancer reached 38 percent, and deaths from the disease reached 68 percent.

The International Agency for World Health Organization Cancer Research revealed that around 3.2 million new breast cancer cases and 1.1 million deaths per year by 2050. In America, breast cases in 2022 are around 275 thousand and will increase to 350 thousand by 2050.

Deaths from the disease in America in 2022 are 43 thousand and are predicted to increase to 64 thousand. Breast cancer cases will increase in developing and low-income countries.

Populations with the highest breast cancer diagnosis rates currently include Australia and New Zealand, Northern Europe and North America. However, the highest death rates include Melanesia, Badminton, and West Africa.

Every minute, four women are diagnosed with breast cancer in the world and one woman dies from the disease. This data is very worrying, said IARC researcher and research co-author, Dr. Joanne Kim, quoted on Tuesday, February 25, 2025.

The risk factors that increase breast cancer are age, family history or genetic influence. Then unhealthy human lifestyle factors, such as alcohol intake and bad physical activity also affect the risk of breast cancer.

The late treatment of breast cancer is also an unavoidable cause of death. It is stated that there are still many women who do not realize breast cancer, so it is too late to get treatment quickly.

With these data increasingly showing urgent need for early detection and good treatment of breast cancer. This is urgently needed to reduce the difficulty of treating and dying patients.

"Protracted progress in early diagnosis and increased access to treatment are essential to address the global gap in breast cancer, and ensure that the goal of reducing breast cancer suffering and death is achieved by all countries around the world," continued Deputy Head of the Cancer Supervision Branch at IARC., Dr. Isabelle Soerjomotram.